Processa Pharmaceuticals, Inc.

PCSA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 12 employees
251
SEC Filings
$2.56
Close 2026-05-29
12
Employees

Business Summary

Part I Corporate Information Processa Pharmaceuticals, Inc. (Processa, we or the Company) was incorporated under the laws of the State of Delaware on March 29, 2011. Our principal executive office is located at 601 21 st Street, Suite 300 Vero Beach, FL 32960. Our telephone number is (772) 453-2899. 4 We make available free of charge on or through our Internet website ( http://www.processapharmaceuticals.com ) our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on For...

Latest Stock Quote

PCSA 2026-05-29 $2.56 O:$2.62 H:$2.63 L:$2.5276 Vol:0.0M VWAP:$2.6052
origin leaf: 9f852046f08fae402c935956e4c3a905878db4c50405c9e0749d3163521fc071

Next Earnings

Q2 FY2026 — expected 2026-09-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-182025-12-310001493152-26-011204EDGAR64K words
2025-03-202024-12-310001641172-25-000070EDGAR
2024-03-292023-12-310001493152-24-011976EDGAR
2023-03-302022-12-310001493152-23-009730EDGAR
2022-03-302021-12-310001493152-22-008156EDGAR
2021-03-252020-12-310001493152-21-006807EDGAR
2020-03-062019-12-310001493152-20-003534EDGAR
2019-03-282018-12-310001493152-19-004137EDGAR
2018-04-162017-12-310001493152-18-005248EDGAR
2017-09-252016-12-310001393905-17-000290EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001493152-25-021069EDGAR18K words
2025-08-072025-06-300001493152-25-011685EDGAR
2025-05-082025-03-310001641172-25-009252EDGAR
2024-10-302024-09-300001493152-24-043058EDGAR
2024-08-132024-06-300001493152-24-031622EDGAR
2024-05-102024-03-310001493152-24-018648EDGAR
2023-11-132023-09-300001493152-23-040472EDGAR
2023-08-102023-06-300001493152-23-027551EDGAR
2023-05-152023-03-310001493152-23-017001EDGAR
2022-11-082022-09-300001493152-22-030942EDGAR
2022-08-112022-06-300001493152-22-022063EDGAR
2022-05-122022-03-310001493152-22-013040EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-190001493152-26-007469EDGAR1K words
2026-01-070001493152-26-000733EDGAR
2025-12-150001493152-25-027680EDGAR
2025-09-120001493152-25-013108EDGAR
2025-09-100001493152-25-012966EDGAR
2025-09-020001493152-25-012567EDGAR
2025-08-250001641172-25-025421EDGAR
2025-08-080001493152-25-011775EDGAR
2025-08-070001493152-25-011680EDGAR
2025-07-250001493152-25-011419EDGAR

251 total filings indexed. 219 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001533743
TickerPCSA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.processapharmaceuticals.com
Listed2013-10-07

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 79bf4b02f0a6b522128676be25a9945a30ab82cd4b6b861b99e6a1390dedde83
parent: 50f150800edb2bcf2a200f050a8d58da457cbb1e466202fb60ef315a3baf102d
content hash: 67aed4e8504d9b4b59172c39d579d2c200239bf9f6e8c7e6863b0e87d6af237b
signed: 2026-06-02T19:02:15.000Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf